Low-dose radioiodine therapy for patients with intermediate- to high-risk differentiated thyroid cancer
ConclusionsThe ablation success rate was much lower than those of earlier studies; the most plausible reason would be that higher risk DTC patients were included in this study. The low-dose RIT routinely performed in Japan might be inadequate for the achievement of successful ablation. At least for patients with Tg > 9 ng/mL at the first RIT, a higher dose of RAI is recommended.
Source: Annals of Nuclear Medicine - Category: Nuclear Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Hormones | Iodine | Japan Health | Nuclear Medicine | PET Scan | Radioiodine Therapy | Study | Thyroid | Thyroid Cancer | Thyroidectomy